相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement
Alan Mackay et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
Daniel J. Toft et al.
MOLECULAR ENDOCRINOLOGY (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
Treatment of triple negative breast cancer (TNBC): current options and future perspectives
M. De Laurentiis et al.
CANCER TREATMENT REVIEWS (2010)
Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
Chad J. Creighton et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Molecular subtyping of breast cancer: ready to use?
Jorma de Ronde et al.
LANCET ONCOLOGY (2010)
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
Britta Weigelt et al.
LANCET ONCOLOGY (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis Are We Ready?
Ping Tang et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Do 'basal-like' breast cancers really exist?
Barry Gusterson
NATURE REVIEWS CANCER (2009)
'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials
L. S. Kilburn
CLINICAL ONCOLOGY (2008)
Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes
Farid Moinfar
PATHOBIOLOGY (2008)
An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)
Enrique Lerma et al.
MODERN PATHOLOGY (2007)
Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases:: clinical implications
Daehoon Park et al.
VIRCHOWS ARCHIV (2007)
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E. de Azambuja et al.
BRITISH JOURNAL OF CANCER (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Differences in risk factors for breast cancer molecular subtypes in a population-based study
Xiaohong R. Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies
Kalliopi P. Siziopikou et al.
BREAST (2007)
Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy
Raihanatou Diallo-Danebrock et al.
CLINICAL CANCER RESEARCH (2007)
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays
Anita L. Bane et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression
E. A. Rakha et al.
HISTOPATHOLOGY (2007)
The phenotypic spectrum of basal-like breast cancers: a critical appraisal
Oluwole Fadare et al.
ADVANCES IN ANATOMIC PATHOLOGY (2007)
Is molecular profiling ready for use in clinical decision making?
John P. A. Ioannidis
ONCOLOGIST (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2006)
Molecular subtypes of breast cancer and amplification of topoisomerase IIα:: predictive role in dose intensive adjuvant chemotherapy
J. Hannemann et al.
BRITISH JOURNAL OF CANCER (2006)
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer
Therese Sorlie et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy
Fabrice Andre et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Metaplastic carcinoma of the breast: a clinicopathological review
G. M. Tse et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Basal-like breast cancer and the BRCA1 phenotype
N. C. Turner et al.
ONCOGENE (2006)
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes
Mi-Jung Kim et al.
HUMAN PATHOLOGY (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Metaplastic breast carcinomas are basal-like tumours
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2006)
Basal-like breast carcinomas: clinical outcome and response to chemotherapy
S. Banerjee et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
L Ein-Dor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation
EA Rakha et al.
JOURNAL OF PATHOLOGY (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
P53 and breast cancer, an update
Marc Lacroix et al.
ENDOCRINE-RELATED CANCER (2006)
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Stefano Calza et al.
BREAST CANCER RESEARCH (2006)
Typical medullary breast carcinomas have a basal/myoepithelial phenotype
J Jacquemier et al.
JOURNAL OF PATHOLOGY (2005)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas
I Matos et al.
VIRCHOWS ARCHIV (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani et al.
CLINICAL CANCER RESEARCH (2005)
Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?
S Leibl et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Limits of predictive models using microarray data for breast cancer clinical treatment outcome
JF Reid et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression
PJ Barnes et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Metaplastic breast carcinomas: Are they of myoepithelial differentiation? Immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers
S Leibl et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Prediction of cancer outcome with microarrays: a multiple random validation strategy
S Michiels et al.
LANCET (2005)
Outcome signature genes in breast cancer: is there a unique set?
L Ein-Dor et al.
BIOINFORMATICS (2005)
Prognostic relevance of basal cytokeratin expression in operable breast cancer
P Potemski et al.
ONCOLOGY (2005)
Genomics in breast cancer - therapeutic implications
PE Lonning et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer
BA Gusterson et al.
BREAST CANCER RESEARCH (2005)
Opinion - Rules of evidence for cancer molecular-marker discovery and validation
DF Ransohoff
NATURE REVIEWS CANCER (2004)
Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes
C Jones et al.
CLINICAL CANCER RESEARCH (2004)
Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference
PJ Park et al.
JOURNAL OF BIOTECHNOLOGY (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Good Old clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
P Edén et al.
EUROPEAN JOURNAL OF CANCER (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept
W Boecker et al.
CELL PROLIFERATION (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
RD Riley et al.
BRITISH JOURNAL OF CANCER (2003)
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome
M van de Rijn et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:: A new cell biological concept
W Böcker et al.
LABORATORY INVESTIGATION (2002)
Adenoid cystic carcinoma of the breast - Molecular markers, treatment, and clinical outcome
G Arpino et al.
CANCER (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Replication validity of genetic association studies
JPA Ioannidis et al.
NATURE GENETICS (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation
C Jones et al.
BRITISH JOURNAL OF CANCER (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases
H Tsuda et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
分享论文
